فهرست مطالب شاهین شمس

Management of pain and inflammation after third molar surgery is an important challenge of this treatment. Various medications have been proposed for pain control after surgery. Comparing the effectiveness of various drugs used in this field can improve dentists' clinical decisions. The aim of this study was to compare the effect of Ketorolac and Gelofen on pain relief in patients undergoing third molar surgery.

This randomized single-blinded clinical trial was performed on 140 patients who were divided into two groups of 70 after receiving the ethical code. The first group was prescribed 400 mg Gelofen capsule for 1 week, while the second group was prescribed 30 mg ketorolac ampule for 1 week. Then, using the visual analog scale (VAS), the patient’s pain was recorded 48 hours, 1 week, and 2 weeks after surgery. Data analysis was carried out using SPSS20 software by descriptive analysis of the results. Ki-square, T-test, and variance analysis were also used for analysis of variables.

The pain level in the ketorolac group after 48 hours, 1 week, and 2 weeks following surgery was significantly less than Gelofen group (P<0.01). Ketorolac effect on pain was irrelevant to the gender, age, and type of tooth variables.

From the results, it was concluded that Ketorolac had greater effect on pain relief after third molar surgery than Gelofen.

The rational prescription of the drug and consideration of its principles affect the treatment outcome. Regarding this, the purpose of this study was to evaluate prescriptions to check if they follow the given principles and investigate the prescribed medications by dentists.

This descriptive-analytical, cross-sectional, and retrospective study was conducted on 238 prescriptions administered by general dentists in Qom, Iran, during the second semester of 2018-2019 academic year in the form of social security and medical services insurance in the RUD Committee of Qom University of Medical Sciences, Qom. The data evaluated in this study included patient age and gender, prescribed medications and their forms, medication category, route of administration, and prescription errors.

Oral, injectable, and topical drugs were prescribed at the frequencies of 97.5%, 34.5%, and 5%, respectively. Furthermore, antibiotics, painkillers, corticosteroids, mouthwash, and other medications were prescribed in 97.6%, 85.7%, 8.4%, 3.8%, and 2% of the prescriptions, respectively. With regard to the prescription problems, 40.3%, 4.2%, 39.5%, 14.3%, 16.4%, and 57.1% of the prescriptions had no drug dose, wrong drug dose, no drug consumption order, wrong drug consumption order, wrong form of medication, and incomplete drug name, respectively. Furthermore, 3.4% of the prescriptions had misspellings, 5.5% of them were eligible. However, none of the prescriptions had problems related to drug interaction or the lack of seal, signature, and date.

In the present study, the error rate of writing prescriptions and administration of antibiotics and analgesics was higher than the figure recommended by the World Health Organization.